双歧杆菌发酵果蔬汁对小鼠免疫功能的影响

目的研究双歧杆菌发酵果蔬汁对小鼠免疫功能的影响。方法将小鼠随机分成纯净水对照组与发酵果蔬汁低、中和高3个剂量组,饮水法喂饲小鼠,测定小鼠胸腺和脾脏指数、腹腔巨噬细胞吞噬功能、血清溶血素测定、皮肤迟发型超敏反应(DTH)程度。结果与对照组比较,3种果蔬汁能显著增强巨噬细胞吞噬功能,增加血清溶血素抗体水平和DTH程度。结论双歧杆菌发酵果蔬汁能提高机体的免疫功能。     

思连康对小鼠腹腔巨噬细胞吞噬率和吞噬指数的影响

目的研究双歧杆菌四联活菌片(商品名:思连康)对小鼠腹腔巨噬细胞吞噬鸡红细胞吞噬率及吞噬指数的影响。方法将SPF小鼠30只随机分成三组,每组10只,Ⅰ组灌胃生理盐水,Ⅱ组灌胃婴儿双歧杆菌菌悬液,Ⅲ组灌胃双歧杆菌四联活菌片菌悬液,每天给药0.5 mL,菌液浓度为1.0×10~8 CFU/mL,连续给药10 d后小鼠腹腔注入2%鸡红细胞悬液1 mL(红细胞数量为2×10~8个/mL),30 min后处死,取小鼠腹腔洗液,观察并记录吞噬鸡红细胞的巨噬细胞数及被吞噬的鸡红细胞数,计算吞噬率及吞噬指数。结果与Ⅰ组相比,Ⅱ组和Ⅲ组小鼠腹腔巨噬细胞吞噬鸡红细胞的吞噬率和吞噬指数均显著升高(Ps0.05),其中Ⅲ组高于Ⅱ组(P0.05)。结论双歧杆菌四联活菌片及其婴儿双歧杆菌通过提高小鼠腹腔巨噬细胞的吞噬率和吞噬指数提高机体的免疫力。     

双歧杆菌对裸鼠腹腔巨噬细胞激活作用的初步观察

用青春型双歧杆菌注射于裸鼠腹腔,分别以中性红吞噬法以及M TT 法检测了裸鼠腹腔巨噬细胞的吞噬能力和能量代谢水平。结果显示双歧杆菌注射组裸鼠腹腔巨噬细胞的吞噬能力和能量代谢水平均显著高于对照组(P< 0.01)。提示青春型双歧杆菌能激活巨噬细胞,增强其吞噬功能,提高其能量代谢水平     

蜜环菌饮料对机体活性的调节作用研究

为了研究蜜环菌饮料对小鼠机体功能的影响,采用环磷酰胺(CY)造模法制作小鼠免疫抑制模型,通过灌胃不同剂量蜜环菌饮料,研究对小鼠机体免疫功能的影响,同时通过测定实验小鼠肠道中细菌总数、大肠杆菌数、乳酸菌和双歧杆菌数等,分析不同剂量的蜜环菌饮料对肠道菌相的影响,最后对小鼠进行了急性毒性试验研究,以检测饮料有无毒副作用。结果表明蜜环菌饮料可明显提高小鼠脾脏和胸腺指数,促进脾脏及胸腺的发育,促进巨噬细胞的吞噬活性,明显增强小鼠的免疫功能,同时还能促进小鼠肠道有益菌的生长,改善肠道微生物区系环境,饮料没有对小鼠产生任何的毒副作用。证明蜜环菌饮料不仅增强机体免疫功能,同时还增强肠道功能,保持和促进机体健康。     

双歧杆菌习腹腔巨噬细胞激活作用的初步观察

用青春型双歧杆菌注射于裸鼠腹腔,分别以中性红吞噬法以及ＭＴＴ法检测了裸鼠腹腔巨噬细胞的吞噬能力和能量代谢水平。结果显示双歧杆菌注射组裸鼠腹腔巨噬细胞的吞噬能力和能量代谢水平均显著高于对照组（Ｐ＜０．０１）。提示青春型双歧杆菌能激活巨噬细胞,增强其吞噬功能,提高其能量代谢水平。     

SL-益生素对小白鼠体重及其单核吞噬细胞功能的影响

研究了SL-益生素(SL-P)对小白鼠体重和单核吞噬细胞功能的影响。经急性毒性实验检查,该益生素无急性毒性,无急性致病作用。灌服SL-P10d后,小鼠体重较对照组有明显提高。经过SL-P处理后,小鼠腹腔巨噬细胞(PMφ)的吞噬率和吞噬指数较对照组有显著提高。灌服SL-P10d后,小鼠单核吞噬细胞的水解酶类:血清溶菌酶(血清LSZ),腹腔巨噬细胞溶菌酶(PMφLSZ),腹腔巨噬细胞酸性磷酸酶(PMφACP)的活性均有不同程度的提高,并呈现一定的剂量依赖关系,表明SL-P对小鼠单核吞噬细胞的吞噬和杀菌功能有明显的促进作用。     

SL-益生素对小白鼠体重及其单核吞噬细胞功能的影响

研究了SL-益生素(SL-P)对小白鼠体重和单核吞噬细胞功能的影响。经急性毒性实验检查,该益生素无急性毒性,无急性致病作用。灌服SL-P10d后,小鼠体重较对照组有明显提高。经过SL-P处理后,小鼠腹腔巨噬细胞(PMφ)的吞噬率和吞噬指数较对照组有显著提高。灌服SL-P10d后,小鼠单核吞噬细胞的水解酶类:血清溶菌酶(血清LSZ),腹腔巨噬细胞溶菌酶(PMφLSZ),腹腔巨噬细胞酸性磷酸酶(PMφACP)的活性均有不同程度的提高,并呈现一定的剂量依赖关系,表明SL-P对小鼠单核吞噬细胞的吞噬和杀菌功能有明显的促进作用。     

口服短小双歧杆菌活菌制剂对机体免疫功能的增强效应

探讨短小双歧杆菌（Bifidobacteriumbreve）对正常机体免疫功能的影响及对免疫低功机体的免疫功能调整作用。以环磷酰胺制备免疫低功模型,检测活菌制剂应用后,小鼠巨噬细胞吞噬功能,自然杀伤（NK）细胞杀伤活性,特异性抗体产生能力及IL—2诱生活性等指标的变化。结果表明短小双歧杆菌活菌制剂口服后可显著提高小鼠巨噬细胞吞噬功能,NK细胞杀伤活性,特异性抗体产生能力3项指标,IL—2诱生活性与对照组相比有一定提高,但差异无显著性。结果提示短小双歧杆菌对提高正常机体的免疫功能,对免疫低功机体有明显的调整作用。     

酪酸梭菌-婴儿型双歧杆菌二联活菌制剂的研究

对酪酸梭菌－婴儿型双歧杆菌二联活菌制剂的特性及功效进行研究和分析。方法：通过实验鼠进行刺激生长试验、活菌数测定、毒理试验、调节肠道菌群试验、免疫调节作用来观察制剂的作用。结果：小鼠肠道中双歧杆菌、乳杆菌、酪酸梭菌数量明显增加,高剂量能增加小鼠抗体生成细胞数。     

双歧杆菌对免疫抑制小鼠白色念珠菌感染的保护作用

为探讨双歧杆菌对白色念珠菌感染的保护作用,作者采用环磷酰胺腹腔注射方法复制了免疫抑制小鼠模型,研究白色念珠菌感染前后两歧双歧杆菌灌饲的保护作用。结果表明：白色念珠菌感染前灌饲两歧双歧杆菌能有效地抑制白色念珠菌在小鼠肠道中的定植,并且保护肠粘膜的完整性。对其机理的研究认为,两歧双歧杆菌可能是通过调整肠道菌群平衡、增加肠道中生理菌群的数量、降低肠道ｐＨ值、以及产生抗菌物质等途径发挥保护作用     

脂磷壁酸的提取工艺及免疫功能的研究

目的确定婴儿双歧杆菌脂磷壁酸（LTA）的最佳提取工艺及其免疫调节作用。方法通过对不同方法提取婴儿双歧杆菌LTA的测定及对植瘤小鼠淋巴细胞的转化来探讨LTA对小鼠细胞免疫的调节作用。结果采用脱脂后水法提取效果最好,与对照组和全菌组相比,LTA使淋巴细胞转化增加。结论婴儿双歧杆菌及其LTA均有免疫功能,但LTA的效果要优于婴儿双歧杆菌。     

Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes

In experiments designed to examine the adverse effects of chronic liposome administration in vivo on the mononuclear phagocyte system (reticuloendothelial system), the presence of drug entrapped in the liposomes may increase the level of reticuloendothelial impairment. We have compared the effects on the mononuclear phagocyte system in mice of chronic administration of empty liposomes with the effects of liposomes containing the anti-leishmanial drug meglumine antimoniate. We have also examined the effect on the mononuclear phagocyte system of continued injections of liposomes containing lipid A, a component of bacterial lipopolysaccharide, which is responsible for macrophage activation. Ten intravenous injections of multilamellar liposomes composed of dipalmitoylphosphatidylcholine and cholesterol (1:0.75 M ratio) were given to ICR mice over a 25-day period. Two individual groups of mice received endotoxin-free liposomes in which meglumine antimoniate was either present or absent. One addition group received liposomes containing lipid A derived from Escherichia coli lipopolysaccharide. A control group received sterile saline injections. In each group, a depression of the phagocytic index, as measured by reduction of uptake of particulate carbon, was observed among some of the individual animals 24 h after the first injection. In many mice a marked splenomegaly was observed. A depressed phagocytic index and splenomegaly were most marked for mice receiving lipid A liposomes. However, there was a large individual variability among mice receiving these preparations and some mice in each group had normal spleen size and a nearly normal phagocytic index. Tissue distribution of liposomes containing [14C]dipalmitoylphosphatidylcholine as a phospholipid marker was examined in all groups in mice 24 h after the last injection.(ABSTRACT TRUNCATED AT 250 WORDS)     

婴儿双歧杆菌对花生过敏小鼠模型肠道Th2反应的调节

目的研究婴儿型双歧杆菌对花生过敏小鼠肠道Th2型反应的调节作用。方法通过应用花生蛋白诱导肠道的Th2型反应,建立食物过敏小鼠模型。过敏小鼠灌胃给予婴儿型双歧杆菌（ATCC菌或CGMCC0313-2）或不做处理。然后分离小鼠小肠黏膜CD4＋T细胞或DC,另取肠黏膜组织进行石蜡包埋甲苯胺蓝染色肥大细胞计数,HE染色进行嗜酸细胞和单个核细胞计数,流式细胞检测CD4＋T中Th2（CD4＋IL4＋T）细胞和Treg（CD4＋CD25＋Foxp3＋T）比例,另取CD4＋T进行CFSE标记,与DC共培养4d后流式细胞检测CD4＋T增殖反应,收集细胞培养液ELISA检测IL-4、IL-5和IL—13分泌水平。结果过敏组小鼠Th2型细胞数,CD4＋T细胞增殖反应,IL4、IL-5和IL-13水平,肠黏膜中肥大细胞、嗜酸性细胞和单个核细胞数均明显高于对照组（P〈0．01）,而Treg数目低于对照组（P〈0．01）,婴儿双歧杆菌干预后,婴儿双歧杆菌组Th2型细胞数,IL4、IL-5和IL-13水平,肠黏膜中肥大细胞、嗜酸性细胞和单个核细胞数均明显低于过敏组（P〈0．01）,而Treg数目高于过敏组（P〈0．01）。结论口服婴儿型双歧杆菌可以抑制花生过敏导致的肠道Th2型反应。     

Could a B-1 Cell Derived Phagocyte “Be One” of the Peritoneal Macrophages during LPS-Driven Inflammation?

The inflammatory response is driven by signals that recruit and elicit immune cells to areas of tissue damage or infection. The concept of a mononuclear phagocyte system postulates that monocytes circulating in the bloodstream are recruited to inflamed tissues where they give rise to macrophages. A recent publication demonstrated that the large increase in the macrophages observed during infection was the result of the multiplication of these cells rather than the recruitment of blood monocytes. We demonstrated previously that B-1 cells undergo differentiation to acquire a mononuclear phagocyte phenotype in vitro (B-1CDP), and we propose that B-1 cells could be an alternative origin for peritoneal macrophages. A number of recent studies that describe the phagocytic and microbicidal activity of B-1 cells in vitro and in vivo support this hypothesis. Based on these findings, we further investigated the differentiation of B-1 cells into phagocytes in vivo in response to LPS-induced inflammation. Therefore, we investigated the role of B-1 cells in the composition of the peritoneal macrophage population after LPS stimulation using osteopetrotic mice, BALB/Xid mice and the depletion of monocytes/macrophages by clodronate treatment. We show that peritoneal macrophages appear in op/op((-/-)) mice after LPS stimulation and exhibit the same Ig gene rearrangement (VH11) that is often found in B-1 cells. These results strongly suggest that op/op((-/-)) peritoneal "macrophages" are B-1CDP. Similarly, the LPS-induced increase in the macrophage population was observed even following monocyte/macrophage depletion by clodronate. After monocyte/macrophage depletion by clodronate, LPS-elicited macrophages were observed in BALB/Xid mice only following the transfer of B-1 cells. Based on these data, we confirmed that B-1 cell differentiation into phagocytes also occurs in vivo. In conclusion, the results strongly suggest that B-1 cell derived phagocytes are a component of the LPS-elicited peritoneal macrophage population.     

Biotherapeutic effects of Bifidobacterium spp. on orogastric and systemic candidiasis in immunodeficient mice

Two commercially available Bifidobacterium spp. (Bifidobacterium infantis and Bifidobacterium lactis) were compared for their capacities to protect immunodeficient bg/bg-nu/nuand bg/bg-nu/+mice from orogastric and lethal candidiasis. Both Bifidobacterium spp. prolonged the survival of Candida albicans-colonized adult and neonatal bg/bg-nu/numice. The bifidobacteria affected the production of antibodies to C. albicans, inhibited disseminated candidiasis, suppressed weight loss associated with C. albicans infection, inhibited the growth of C. albicans in the alimentary tract, inhibited systemic candidiasis of endogenous origin, and decreased the severity of gastric candidiasis in both mouse strains. B. infantis inhibited systemic candidiasis of endogenous origin better than B. lactis; however, B. lactis was significantly more effective at inhibiting C. albicans colonization of the alimentary tract, suppressing gastric candidiasis, and protecting bg/bg-nu/numice from lethal candidiasis than B. infantis. These results show that Bifidobacterium spp. can protect immunodeficient mice from candidiasis but different species manifest quantitative and qualitative differences in their probiotic and biotherapeutic effects.     

Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation

Host defence against infection requires a range of innate and adaptive immune responses that may lead to tissue damage. Such immune-mediated pathologies can be controlled with appropriate T regulatory (Treg) activity. The aim of the present study was to determine the influence of gut microbiota composition on Treg cellular activity and NF-kappaB activation associated with infection. Mice consumed the commensal microbe Bifidobacterium infantis 35624 followed by infection with Salmonella typhimurium or injection with LPS. In vivo NF-kappaB activation was quantified using biophotonic imaging. CD4+CD25+Foxp3+ T cell phenotypes and cytokine levels were assessed using flow cytometry while CD4+ T cells were isolated using magnetic beads for adoptive transfer to na?ve animals. In vivo imaging revealed profound inhibition of infection and LPS induced NF-kappaB activity that preceded a reduction in S. typhimurium numbers and murine sickness behaviour scores in B. infantis-fed mice. In addition, pro-inflammatory cytokine secretion, T cell proliferation, and dendritic cell co-stimulatory molecule expression were significantly reduced. In contrast, CD4+CD25+Foxp3+ T cell numbers were significantly increased in the mucosa and spleen of mice fed B. infantis. Adoptive transfer of CD4+CD25+ T cells transferred the NF-kappaB inhibitory activity. Consumption of a single commensal micro-organism drives the generation and function of Treg cells which control excessive NF-kappaB activation in vivo. These cellular interactions provide the basis for a more complete understanding of the commensal-host-pathogen trilogue that contribute to host homeostatic mechanisms underpinning protection against aberrant activation of the innate immune system in response to a translocating pathogen or systemic LPS.     

The suppressive effect of bifidobacteria on Bacteroides vulgatus,a putative pathogenic microbe in inflammatory bowel disease

Bacteroides, a predominant commensal bacteria in the gut, are thought to be responsible for the development of inflammatory bowel disease (IBD). In the present study, we examined whether or not bifidobacteria suppress B. vulgatus, a representative pathogenic Bacteroides species, in both the coculture system and the gnotobiotic murine model. As a result, Bifidobacterium infantis 1222 highly inhibited the growth of B. vulgatus in the coculture and also significantly suppressed the systemic antibody response raised by B. vulgatus colonizing the gut in gnotobiotic mice. Colonization of the mice by B. vulgatus increased the number of Peyer's patch (PP) cells bearing PNA (peanut agglutinin)+/anti-kappa+ phenotype, which represents plasma cell-like B cells. Moreover, treatment of those B. vulgatus-implanted mice with B. infantis 1222 abrogated such increase in the number of PNA+/anti-kappa+ cells. These results thus suggested that B. infantis 1222 protected the gut epithelial layer including the PP from being invaded by Bacteroides, thereby suppressing the systemic antibody response raised by Bacteroides.     

Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis

Mononuclear phagocytes are critical components of the innate host defense of the lung to inhaled bacterial pathogens. The monocyte chemotactic protein CCL2 plays a pivotal role in inflammatory mononuclear phagocyte recruitment. In this study, we tested the hypothesis that increased CCL2-dependent mononuclear phagocyte recruitment would improve lung innate host defense to infection with Streptococcus pneumoniae. CCL2 transgenic mice that overexpress human CCL2 protein in type II alveolar epithelial cells and secrete it into the alveolar air space showed a similar proinflammatory mediator response and neutrophilic alveolitis to challenge with S. pneumoniae as wild-type mice. However, CCL2 overexpressing mice showed an improved pneumococcal clearance and survival compared with wild-type mice that was associated with substantially increased lung mononuclear phagocyte subset accumulations upon pneumococcal challenge. Surprisingly, CCL2 overexpressing mice developed bronchiolitis obliterans upon pneumococcal challenge. Application of anti-CCR2 Ab MC21 to block the CCL2-CCR2 axis in CCL2 overexpressing mice, though completely abrogating bronchiolitis obliterans, led to progressive pneumococcal pneumonia. Collectively, these findings demonstrate the importance of the CCL2-CCR2 axis in the regulation of both the resolution/repair and remodelling processes after bacterial challenge and suggest that overwhelming innate immune responses may trigger bronchiolitis obliterans formation in bacterial lung infections.     

High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis

Macrophage C3 receptors are normally immobilized in the plane of the cells' plasma membrane and are unable to promote phagocytosis even though they promote avid particle binding. We have previously identified a lymphokine that activates macrophage C3 receptors for phagocytosis both in vitro and in vivo, and others have found that certain types of nonimmunologically mediated inflammation are also able to activate mononuclear phagocyte C3 receptors. These findings raised the possibility that macrophage C3 receptor activation is a universal consequence of inflammation. We sought in the present experiments to determine whether or not inflammation induced by microbial infection in a nonimmune host resulted in activation of macrophage C3 receptors. We injected mice i.p. with either viable microorganisms, microbe-containing immune complexes, or bacterial LPS. Macrophages were harvested by peritoneal lavage 4 days later; nearly all lavage fluids grew the microorganism with which the mouse had been injected, indicating that an infection had been established. Monolayers of macrophages were established and their interaction with sheep E coated with C3 (EIgMC) was determined. All macrophages bound EIgMC, but only macrophages from mice injected with either very high concentrations of LPS or microbe-containing immune complexes ingested them. C3 receptors of macrophages that ingested EIgMC were mobile; others were not. Thus, inflammation induced by microbial infection does not commonly, if at all, activate macrophage C3 receptors; microbe-containing immune complexes and high concentrations of LPS do. The mechanism of receptor activation in each case is C3 receptor mobilization, which is probably mediated by a lymphokine.